GCG and type 1 diabetes mellitus: In either case, correcting the impaired diurnal pattern of liver glycogen accretion and utilization in people with type 1 diabetes could be of therapeutic value by increasing glucagon levels under nonhypoglycemic conditions that, based on the current data, would persist as the plasma glucose levels fall, and aid in recovery by enhancing HGP.